Windtree Therapeutics Inc.
13F holders, Q1 2024 (March 31)9holders
1famous investor
$0.35avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding Windtree Therapeutics Inc. in their 13F filings. The largest holders were Deerfield Management Company, L.P. ($215K), Vanguard Group Inc. ($15K) and Geode Capital Management, LLC ($5K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Windtree Therapeutics Inc.
- CUSIP
- 97382D402
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $215K |
| Exits | 3 | $126K |
Ownership 9 holders
| Deerfield Management Company, L.P. | 0.00% | New | 608,272 | $215K |
| Vanguard Group Inc. | 0.00% | No change | 41,640 | $15K |
| Geode Capital Management, LLC | 0.00% | Reduce -1.4% | 13,991 | $5K |
| Citadel Advisors | 0.00% | Reduce -72.0% | 10,655 | $4K |
| Wells Fargo & Company | 0.00% | Add +28.1% | 41 | $15 |
| UBS Group AG | 0.00% | Reduce -98.2% | 9 | $3 |
| US Bancorp \de | 0.00% | No change | 3 | $1 |
| IFP Advisors, Inc | 0.00% | No change | 1 | $0 |
| Osaic Holdings, Inc. | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is WINDTREE THERAPEUTICS INC's weight in each manager's 13F, not the share of Windtree Therapeutics Inc. the manager owns.